Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Advanced Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04912466
What this trial is testing

IBI322 Monotherapy or Combination Therapy in Subjects With Advanced Malignant Tumors.

Who this might be right for
Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 61
Early research (Phase 1)Active Not RecruitingNCT01591356
What this trial is testing

EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center 49
Early research (Phase 1)Active Not RecruitingNCT06723964
What this trial is testing

AP505 Injection in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
AP Biosciences Inc. 35
Very early researchLooking for participantsNCT06380309
What this trial is testing

A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE

Who this might be right for
Advanced Malignant Solid Tumor of Digestive System
Peking University 89
Early research (Phase 1)Looking for participantsNCT07631793
What this trial is testing

Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

Who this might be right for
Malignant Neoplasms
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. 76
Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06400238
What this trial is testing

Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT01184807
What this trial is testing

Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
Otsuka Beijing Research Institute 51
Early research (Phase 1)Ended earlyNCT04958434
What this trial is testing

Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic CancersMetastatic Human Papillomavirus-Related Malignant Neoplasm
Transcenta Therapeutics (Hangzhou) Co., Ltd. 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Early research (Phase 1)Active Not RecruitingNCT02595931
What this trial is testing

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+15 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT04870645
What this trial is testing

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

Who this might be right for
Malignant Solid Neoplasm
M.D. Anderson Cancer Center 15
Not applicableStudy completedNCT05058339
What this trial is testing

Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmCOVID-19 InfectionHematopoietic and Lymphoid Cell Neoplasm+4 more
M.D. Anderson Cancer Center 223
Early research (Phase 1)Study completedNCT01296568
What this trial is testing

C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Advanced Cancer
Eli Lilly and Company 3
Testing effectiveness (Phase 2)Ended earlyNCT01001221
What this trial is testing

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Who this might be right for
Neoplasms, Malignant
Sanofi 19
Very early researchNot Yet RecruitingNCT07657416
What this trial is testing

NK521 in the Treatment of Advanced Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Ovarian CancerMalignant Ascites
Base Therapeutics (Shanghai) Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06942104
What this trial is testing

Imaging of Solid Tumors Using 18F-TRX

Who this might be right for
Solid TumorSolid CarcinomaCastration-Resistant Prostate Carcinoma+7 more
Rahul Aggarwal 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195555
What this trial is testing

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
National Cancer Institute (NCI) 3
Early research (Phase 1)Looking for participantsNCT04693468
What this trial is testing

Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
M.D. Anderson Cancer Center 111
Testing effectiveness (Phase 2)Looking for participantsNCT06818643
What this trial is testing

Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Who this might be right for
Advanced Solid TumorsMalignant Neoplasm
Merck Sharp & Dohme LLC 270
Next Page